Bhawana Saluja

Regulatory Considerations for Approval of Generic Inhalation Drug Products in the US, EU, Brazil, China, and India

Sau L. Lee, Bhawana Saluja, Alfredo García‐Arieta et al. · The AAPS Journal · 2015 · 62 citations · Full text

Drug Safety, Asthma, Regulatory Approval +8

Novel low molecular weight lignins as potential anti-emphysema agents: In vitro triple inhibitory activity against elastase, oxidation and inflammation

Bhawana Saluja, Jay N. Thakkar, Hua Li et al. · Pulmonary Pharmacology & Therapeutics · 2012 · 40 citations · Full text

Allergy, Medicine, Potential Anti-emphysema Agents +5

Predicting Pulmonary Pharmacokinetics from In Vitro Properties of Dry Powder Inhalers

Sharvari Bhagwat, Uta Schilling, Mong‐Jen Chen et al. · Pharmaceutical Research · 2017 · 40 citations

Asthma, Lung Deposition, Medicine +7

Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers

Jagdeep Shur, Bhawana Saluja, Sau Lee et al. · The AAPS Journal · 2015 · 33 citations · Full text

Asthma, Lung Deposition, Excipients +7

Patient Focus and Regulatory Considerations for Inhalation Device Design: Report from the 2015 IPAC-RS/ISAM Workshop

Nicolás Roche, G. Scheuch, J.N. Pritchard et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2016 · 27 citations

Asthma, Lung Deposition, Pulmonary Care +12